Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation ; volume:61 ; number:4 ; day:20 ; month:1 ; year:2022 ; pages:465-479 ; date:4.2022
Clinical pharmacokinetics ; 61, Heft 4 (20.1.2022), 465-479, 4.2022
- Creator
-
Angiolillo, Dominick J.
Prats, Jayne
Deliargyris, Efthymios N.
Schneider, David J.
Scheiman, James
Kimmelstiel, Carey
Steg, Ph. Gabriel
Alberts, Mark
Rosengart, Todd
Mehran, Roxana
Bhatt, Deepak L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-021-01090-2
- URN
-
urn:nbn:de:101:1-2022062118522126151345
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Angiolillo, Dominick J.
- Prats, Jayne
- Deliargyris, Efthymios N.
- Schneider, David J.
- Scheiman, James
- Kimmelstiel, Carey
- Steg, Ph. Gabriel
- Alberts, Mark
- Rosengart, Todd
- Mehran, Roxana
- Bhatt, Deepak L.
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study
No pharmacodynamic (PD) and pharmacokinetic (PK) interaction of riociguat (BAY 63-2521) and aspirin
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study
No pharmacodynamic (PD) and pharmacokinetic (PK) interaction of riociguat (BAY 63-2521) and aspirin
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study
No pharmacodynamic (PD) and pharmacokinetic (PK) interaction of riociguat (BAY 63-2521) and aspirin
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments